SecSonar.com

Black Diamond Therapeutics, Inc. (BDTX)

Black Diamond Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Black Diamond Therapeutics, Inc. (BDTX) is a Biotechnology company based in US with a market capitalization of $130.1M. The company generated $29.6M in free cash flow. This page tracks BDTX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 24 employees · IPO Jan 31, 2020

Valuation

Valuation & price

$2.75 · as of May 17, 2026 · -43.5% vs 52w high

7.1

P/E ratio

Latest-FY diluted EPS

1.16

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.87$3.24$1.61Jul 25Dec 25Jul 26Jul 7, 25$2.50Jul 9, 25$2.64Jul 11, 25$2.87Jul 15, 25$2.95Jul 17, 25$3.21Jul 21, 25$3.15Jul 23, 25$3.19Jul 25, 25$2.97Jul 29, 25$2.78Jul 31, 25$2.66Aug 4, 25$2.83Aug 6, 25$2.69Aug 11, 25$2.31Aug 13, 25$2.77Aug 15, 25$2.76Aug 19, 25$2.65Aug 21, 25$2.71Aug 25, 25$2.87Aug 27, 25$2.87Aug 29, 25$2.75Sep 3, 25$2.88Sep 5, 25$2.94Sep 9, 25$3.25Sep 11, 25$3.37Sep 16, 25$3.17Sep 18, 25$3.35Sep 22, 25$3.42Sep 24, 25$3.26Sep 26, 25$3.40Sep 30, 25$3.79Oct 2, 25$3.73Oct 6, 25$3.92Oct 8, 25$3.99Oct 10, 25$4.09Oct 14, 25$3.76Oct 16, 25$4.18Oct 21, 25$3.96Oct 23, 25$3.88Oct 27, 25$3.95Oct 29, 25$3.82Oct 31, 25$3.87Nov 4, 25$3.62Nov 6, 25$3.98Nov 10, 25$4.36Nov 12, 25$4.87Nov 14, 25$4.01Nov 18, 25$3.97Nov 20, 25$3.81Nov 25, 25$3.87Nov 28, 25$3.82Dec 2, 25$3.45Dec 4, 25$2.71Dec 8, 25$2.75Dec 10, 25$2.67Dec 12, 25$2.79Dec 16, 25$2.62Dec 18, 25$2.54Dec 22, 25$2.60Dec 24, 25$2.67Dec 29, 25$2.49Jan 2, 26$2.49Jan 6, 26$2.60Jan 8, 26$2.78Jan 12, 26$2.64Jan 14, 26$2.79Jan 16, 26$2.56Jan 21, 26$2.57Jan 23, 26$2.61Jan 27, 26$2.59Jan 29, 26$2.63Feb 2, 26$2.54Feb 4, 26$2.39Feb 9, 26$2.24Feb 11, 26$2.22Feb 13, 26$2.22Feb 18, 26$2.26Feb 20, 26$2.33Feb 24, 26$2.55Feb 26, 26$2.50Mar 2, 26$2.43Mar 4, 26$2.46Mar 6, 26$2.15Mar 10, 26$2.27Mar 12, 26$2.13Mar 17, 26$2.23Mar 19, 26$2.15Mar 23, 26$2.15Mar 25, 26$2.19Mar 27, 26$2.03Mar 31, 26$2.13Apr 2, 26$2.39Apr 7, 26$2.45Apr 9, 26$2.58Apr 13, 26$2.72Apr 15, 26$2.87Apr 17, 26$3.06Apr 22, 26$3.35Apr 24, 26$2.97Apr 28, 26$2.70Apr 30, 26$2.65May 4, 26$2.70May 6, 26$2.82May 8, 26$2.99May 12, 26$2.83May 14, 26$2.86May 18, 26$2.58May 20, 26$3.60May 22, 26$2.28May 28, 26$2.25Jun 1, 26$2.26Jun 3, 26$2.10Jun 5, 26$1.97Jun 9, 26$1.90Jun 11, 26$1.82Jun 15, 26$1.72Jun 17, 26$1.67Jun 22, 26$1.61Jun 24, 26$1.86Jun 26, 26$1.71Jul 2, 26$2.01
$1.6152-week range$4.87
Loading valuation history…

Fundamentals

Key fundamentals

$130.1M

Market cap

—

Revenue growth (YoY)

99.5%

Gross margin

$29.6M

Free cash flow (USD)

-$113.6M

Net debt

Net cash position

3.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$0.00FY 2025$70.0M
$0$70M

Free cash flow by year

2017 → 2025

FY 2017$-2.4MFY 2018$-8.5MFY 2019$-24.7MFY 2020$-52.3MFY 2021$-102.9MFY 2022$-85.3MFY 2023$-66.8MFY 2024$-62.3MFY 2025$29.6M
-$2.4M$29.6M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 29, 2026Filing
  • 8-K eventPhase 2 Trial ResultsMay 21, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing

Questions

Frequently asked questions

What is Black Diamond Therapeutics, Inc.'s market cap?

Black Diamond Therapeutics, Inc. (BDTX) has a market capitalization of $130.1M.

What is BDTX's P/E ratio?

BDTX trades at a price-to-earnings ratio of 7.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is BDTX's price-to-book (P/B) ratio?

BDTX trades at 1.16 times book value per share.

Are insiders buying BDTX stock?

SEC Form 4 filings show no open-market insider buys at Black Diamond Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

KRRO

Korro Bio, Inc.

$129.6M

IKT

Inhibikase Therapeutics, Inc.

$125.3M

HRTX

Heron Therapeutics, Inc.

$135.1M

CRDF

Cardiff Oncology, Inc.

$124.8M

MIST

Milestone Pharmaceuticals Inc.

$124.1M

QTTB

Q32 Bio Inc.

$137.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.